[웨비나] How to Evolve mRNA Production and Purification in the Aftermath of COVID-19 Vaccine Development [On-demand]
작성자
admin
작성일
2021-09-06 17:04
조회
3091
[ Webinar ]
How to Evolve mRNA Production and Purification in the Aftermath of COVID-19 Vaccine Development
[ Overview ]
The COVID-19 vaccines have demonstrated the potential of mRNA-based platforms, but so far manufacturers have focused primarily on safety and efficacy of mRNA vaccines and not on so much on how to optimize production and purification processes for the future. Monolithic chromatography technologies should be considered by biopharmaceutical manufacturers looking to take their mRNA processing to the next level. Our scientists have been developing mRNA processes in our labs in Ajdovščina, Slovenia, and they have amassed a wealth of information and insights about how next-generation processes can be developed and implemented.
This webinar will feature a panel discussion where our experts will discuss current approaches and bottlenecks of mRNA production
and lay out their vision for truly optimized next-generation processes. Please join our mRNA experts as they:
- Review the real-world challenges our customers faced in their mRNA manufacturing efforts and
how Sartorius partnered with them to develop innovative solutions
- Underscore the importance of flexibility in mRNA purification and highlight some options from the Sartorius mRNA purification toolbox,
such as the Oligo dT affinity monolith and PrimaS non-affinity monolith columns for capture of mRNA
- Present a method for rapid analytical monitoring of IVT reactions with CIMac® PrimaS
> Webinar Registration